NEW YORK, Jan. 27 (GenomeWeb News) - Shares in Affymetrix were up 11.95 percent, or $4.34, at $40.67 in late-afternoon trading today, one day after the company reported substantial gains in revenue during the fourth quarter.

 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

In Nature this week: ash dieback disease fungal genome, and more.